Wockhardt
Clinical trials sponsored by Wockhardt, explained in plain language.
-
New antibiotic combo battles tough kidney infections in hospital trial
Disease control CompletedThis study tested whether a new antibiotic combination (cefepime-zidebactam) works as well as a standard antibiotic (meropenem) for treating serious urinary tract or kidney infections that require hospitalization. About 530 adults with these infections received one of the two tre…
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Early safety check for new antibiotic combos
Knowledge-focused CompletedThis early-stage study tested how the body absorbs and clears three different antibiotic treatments in healthy adults. Thirty participants received single doses of two antibiotics alone and then together, with breaks in between. The main goal was to measure drug levels in the blo…
Phase: PHASE1 • Sponsor: Wockhardt • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
First human tests begin for new antibiotic helper drug
Knowledge-focused CompletedThis early-stage study aimed to check if multiple doses of an experimental drug called zidebactam are safe for healthy people and to see how the body processes it. The drug is being developed to help fight tough bacterial infections. A small group of 21 healthy adults received ei…
Phase: PHASE1 • Sponsor: Wockhardt • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC
-
Scientists track experimental Drug's journey through the body
Knowledge-focused CompletedThis early-stage study aimed to understand how the body breaks down and eliminates an experimental antibiotic called zidebactam. Eight healthy male volunteers received a single dose containing a tiny, safe amount of radioactive tracer to track the drug's path. Researchers measure…
Phase: PHASE1 • Sponsor: Wockhardt • Aim: Knowledge-focused
Last updated Mar 03, 2026 14:06 UTC